Mancozeb


Curated chemical-disease associations from CTD
Disease IDDisease nameReference
MESH:C536875 Arrest of spermatogenesis PMID:21782674
MESH:C562565 Uterine Anomalies PMID:32446389
MESH:C564424 Genitourinary Tract Anomalies PMID:32446389
MESH:D000014 Abnormalities, Drug-Induced PMID:3715882; PMID:982313
MESH:D000382 Agricultural Workers' Diseases PMID:15583372; PMID:15864902; PMID:15901622; PMID:16132792; PMID:20061368; PMID:20164001; PMID:8807224
MESH:D001172 Arthritis, Rheumatoid PMID:27285288
MESH:D001943 Breast Neoplasms PMID:12562632
MESH:D002471 Cell Transformation, Neoplastic PMID:11394711
MESH:D002493 Central Nervous System Diseases PMID:21266532
MESH:D002869 Chromosome Aberrations PMID:27235710; PMID:2797033; PMID:7678149
MESH:D003643 Death PMID:30116484
MESH:D004428 Ear Neoplasms PMID:12562632
MESH:D004480 Ectromelia PMID:11402670
MESH:D004485 Eczema PMID:2525102
MESH:D004677 Encephalocele PMID:11402670
MESH:D005313 Fetal Death PMID:11402670
MESH:D005327 Fetal Resorption PMID:11402670; PMID:3715882
MESH:D006528 Carcinoma, Hepatocellular PMID:12562632
MESH:D006529 Hepatomegaly PMID:33217513
MESH:D006965 Hyperplasia PMID:2792977
MESH:D006967 Hypersensitivity PMID:7808348
MESH:D006980 Hyperthyroidism PMID:20061368
MESH:D007037 Hypothyroidism PMID:20061368
MESH:D007246 Infertility PMID:22369882
MESH:D007636 Keratoacanthoma PMID:2208079
MESH:D007938 Leukemia PMID:12562632
MESH:D007945 Leukemia, Lymphoid PMID:16132792
MESH:D008107 Liver Diseases PMID:2792977
MESH:D008223 Lymphoma PMID:12562632
MESH:D008545 Melanoma PMID:20164001
MESH:D008599 Menstruation Disturbances PMID:15583372
MESH:D009069 Movement Disorders PMID:30116484
MESH:D009374 Neoplasms, Experimental PMID:12562632
MESH:D009401 Nephrosis PMID:12237977; PMID:12425114
MESH:D009410 Nerve Degeneration PMID:15350641; PMID:21376751; PMID:21922334; PMID:23103283
MESH:D009436 Neural Tube Defects PMID:15864902
MESH:D009783 Dermatitis, Occupational PMID:2933217; PMID:8807224
MESH:D009845 Oligospermia PMID:29283200; PMID:8671712
MESH:D010049 Ovarian Diseases PMID:11499999; PMID:15803961; PMID:32446389
MESH:D010190 Pancreatic Neoplasms PMID:12562632; PMID:16965848; PMID:8504486; PMID:8603375
MESH:D010212 Papilloma PMID:2208079
MESH:D010243 Paralysis PMID:11402670
MESH:D011041 Poisoning PMID:22369882; PMID:23103283; PMID:30116484
MESH:D011297 Prenatal Exposure Delayed Effects PMID:11394711; PMID:32066110
MESH:D012141 Respiratory Tract Infections PMID:32066110
MESH:D012162 Retinal Degeneration PMID:15901622
MESH:D012516 Osteosarcoma PMID:12562632
MESH:D012878 Skin Neoplasms PMID:1733566; PMID:1814835; PMID:3135958; PMID:3652029
MESH:D013733 Testicular Diseases PMID:21782674; PMID:30037311; PMID:9009508
MESH:D013959 Thyroid Diseases PMID:21266532; PMID:21800831
MESH:D013964 Thyroid Neoplasms PMID:12562632
MESH:D014456 Ulcer PMID:37009748
MESH:D015430 Weight Gain PMID:24530807; PMID:33217513; PMID:3715882
MESH:D015431 Weight Loss PMID:11402670; PMID:12237977; PMID:12425114; PMID:29673962
MESH:D017449 Dermatitis, Allergic Contact PMID:8807224
MESH:D017454 Dermatitis, Photoallergic PMID:8930488
MESH:D018908 Muscle Weakness PMID:3715882
MESH:D019636 Neurodegenerative Diseases PMID:23103283; PMID:28330765
MESH:D019954 Neurobehavioral Manifestations PMID:28330765
MESH:D020258 Neurotoxicity Syndromes PMID:15895843
MESH:D020734 Parkinsonian Disorders PMID:20960484
MESH:D020964 Embryo Loss PMID:12064561; PMID:22369882
MESH:D048629 Micronuclei, Chromosome-Defective PMID:7992229
MESH:D053627 Asthenozoospermia PMID:29283200
MESH:D056486 Chemical and Drug Induced Liver Injury PMID:37009748
MESH:D064806 Dysbiosis PMID:36963522
MESH:D065626 Non-alcoholic Fatty Liver Disease PMID:27016407

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.